All markets
Merck & Moderna merger/acquisition announced in 2026?
5%chance
- Yes4.2%
Outcomes
- Yes5%
4.7¢ per share
- No95%
95.3¢ per share
Order book
Trade YesMidpoint 4.2¢Spread 5.7¢
Bids
| Price | Shares | Total |
|---|---|---|
| 1.3¢ | 57.65 | $0.75 |
| 1.1¢ | 289 | $3.18 |
| 1¢ | 737.49 | $7.37 |
| 0.9¢ | 20 | $0.18 |
| 0.6¢ | 16.77 | $0.10 |
| 0.5¢ | 377.55 | $1.89 |
| 0.4¢ | 212.67 | $0.85 |
| 0.3¢ | 213.42 | $0.64 |
| 0.2¢ | 20.09 | $0.04 |
| 0.1¢ | 3,638.65 | $3.64 |
Asks
| Price | Shares | Total |
|---|---|---|
| 7¢ | 50 | $3.50 |
| 7.1¢ | 53.82 | $3.82 |
| 8.3¢ | 20 | $1.66 |
| 8.5¢ | 20 | $1.70 |
| 9.3¢ | 80 | $7.44 |
| 13.9¢ | 8.13 | $1.13 |
| 14¢ | 300 | $42.00 |
| 72.2¢ | 7 | $5.05 |
| 72.3¢ | 20 | $14.46 |
| 72.4¢ | 28.98 | $20.98 |
Rules
This market will resolve to "Yes" if it is officially announced that Merck & Co. (MRK) will be, has been, or is being acquired by or merged with Moderna (MRNA), or vice versa, by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A qualifying merger or acquisition must encompass both MRK and MRNA or their subsidiaries. An announcement by MRK or MRNA within this market's timeframe will qualify for a "Yes" resolution, regardless of whether or when the announced acquisition/merger actually occurs. A bid or offer announcement without the indication of a settled agreement will not qualify. Announcements of partial sales may count, as long as the acquiring company announces the acquisition of a controlling interest in the other company. A "controlling interest" refers to a change in ownership sufficient to control the company's strategic decisions (typically more than 50% of equity, or equivalent control via voting and governance rights). Transactions or investments that do not result in a transfer of controlling interest will not count. The primary resolution source for this market will be official information from MRK and MRNA; however, a consensus of credible reporting may also be used.